Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesInterventions for prevention of post-operative recurrence of Crohn's disease
Cochrane Reviews, 10/27/09
Doherty G et al. – This review examines the results of published studies which have looked at the effect of using medication following surgery for Crohn's disease as a mean of preventing the return (recurrence) of inflammation. Where possible, the results of studies were combined to compare the results of different treatments. A number of medications appeared to reduce the recurrence of inflammation, including metronidazole, mesalamine, azathioprine, 6–mercaptopurine and infliximab. Given that some of these medications have significant side–effects, the decision to use them requires a careful balancing of the risks and benefits for each individual patient.
Related Articles
Postoperative Management of Crohn Disease
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 81%
Imaging of Perianal Fistulas
Clinical Gastroenterology and Hepatology, 10/07/09
Relevance Score: 80%
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 69%
C-Reactive Protein and Disease Activity in Children with Crohns Disease
Digestive Diseases and Sciences, 10/26/09
Relevance Score: 69%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
New England Journal of Medicine, 11/20/09
Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD)
Inflammatory Bowel Disease, 11/18/09
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Inflammatory Bowel Disease, 11/18/09
Sponsor
Article Search
Sponsor